Literature DB >> 5070921

Isolation of mycoplasmas from lungs by a perfusion technique.

D Taylor-Robinson, F W Denny, G W Thompson, A C Allison, P A Mårdh.   

Abstract

Mesh：

Year:  1972        PMID： 5070921     DOI： 10.1007/bf02122003

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  10 in total

1.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

Authors:  R M CHANOCK; L HAYFLICK; M F BARILE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-01-15       Impact factor: 11.205

2.  Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.

Authors:  G W Fernald; W A Clyde
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

3.  The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice.

Authors:  F W Denny; D Taylor-Robinson; A C Allison
Journal:  J Med Microbiol       Date:  1972-08       Impact factor: 2.472

4.  Immunologic aspects of experimental Mycoplasma pneumoniae infection.

Authors:  G W Fernald
Journal:  J Infect Dis       Date:  1969-03       Impact factor: 5.226

5.  The isolation of T-mycoplasmas from the urogenital tract of bulls.

Authors:  D Taylor-Robinson; M Thomas; P L Dawson
Journal:  J Med Microbiol       Date:  1969-11-04       Impact factor: 2.472

6.  Mycoplasmacidal action of normal tissue extracts.

Authors:  E Kaklamanis; L Thomas; K Stavropoulos; I Borman; C Boshwitz
Journal:  Nature       Date:  1969-03-01       Impact factor: 49.962

7.  Mycoplasma in leukemic and nonleukemic mice.

Authors:  J G Tully; R Rask-Nielsen
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

8.  Adsorption of Mycoplasma pneumoniae to neuraminic acid receptors of various cells and possible role in virulence.

Authors:  O Sobeslavsky; B Prescott; R M Chanock
Journal:  J Bacteriol       Date:  1968-09       Impact factor: 3.490

9.  Utilization of neuraminic acid receptors by mycoplasmas.

Authors:  R J Manchee; D Taylor-Robinson
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

10.  Immunopathology of experimental Mycoplasma pneumoniae disease.

Authors:  W A Clyde
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441
  10 in total
  7 in total

1.  Effect of immunosuppression on arthritis in mice induced by Mycoplasma pulmonis.

Authors:  G Taylor; D Taylor-Robinson; G Slavin
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

2.  New approaches to the isolation of mycoplasmas.

Authors:  P A Mårdh; D Taylor-Robinson
Journal:  Med Microbiol Immunol       Date:  1973       Impact factor: 3.402

3.  Capsular material of Mycoplasma gallisepticum and its possible relevance to the pathogenic process.

Authors:  M Tajima; T Yagihashi; Y Miki
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

4.  Comparison of techniques for primary isolation of respiratory Mycoplasma pulmonis from rats.

Authors:  R H Lentsch; J E Wagner; D R Owens
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

5.  Pneumonia in mice produced by Neisseria gonorrhoeae.

Authors:  A P Johnson; D Taylor-Robinson; G Slavin
Journal:  Br J Vener Dis       Date:  1977-02

6.  Comparison of Chalquest and Hayflick media, with and without ammonium reineckate, for isolating Mycoplasma pulmonis from rats.

Authors:  W C Lai; S P Pakes; C Stefanu; Y S Lu
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

7.  Protective effect of vaccines on Mycoplasma pulmonis-induced respiratory disease of mice.

Authors:  G Taylor; C J Howard; R N Gourlay
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.